Cancer Cell International invites you to join our team of reviewers. For consideration, please send your CV to aoife.buckley@biomedcentral.com.
New reviewer recruitment
Aims and scope
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. Read more here.
Articles
-
-
Uev1A promotes breast cancer cell survival and chemoresistance through the AKT-FOXO1-BIM pathway
-
Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
-
Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways
-
SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways
-
Role of stem cells in cancer therapy and cancer stem cells: a review
-
Acidic extracellular microenvironment and cancer
-
Understanding the colon cancer stem cells and perspectives on treatment
-
B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
-
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status
Trending articles
Click here to view which articles have been shared the most in the last month!
Editor-in-Chief
Domenico Coppola, Moffitt Cancer Center and Florida Digestive Health Specialists, USA
Spotlight: Associate Editor
Andy Tao Yin Lau
After obtaining his PhD degree (Molecular Biology) at the University of Hong Kong, Dr. Andy Tao Yin Lau joined the University of Minnesota (USA) as a postdoctoral fellow on Cancer and Epigenetics Research. Since 2011, he has been working as a Principal Investigator and established the Laboratory of Cancer Biology and Epigenetics at Shantou University Medical College (P. R. China). Dr. Lau’s research team studies the molecular basis of cancers by using “OMICS” approaches. For example, he has applied proteomic-based platform to study the proteome and epiproteome responses of carcinogen-exposed lung cells/anticancer drug-treated lung cancer cells and the identification of novel biomarker signatures. Moreover, he is interested in functional characterization of novel protein post-translational modifications and their relationship in human diseases including cancers.
Spotlight: Editorial Board
Koraljka Gall Trošelj
Dr. Koraljka Gall Trošelj earned her MD degree at the University of Zagreb (Croatia), from where she received both a Masters and PhD degree in biomedicine – molecular oncology. She is a Fulbright Scholar who spent two years in the US at the Weill Cornell Medical School in New York City. Dr. Gall Trošelj is currently the head of the Laboratory for Epigenomics in the Division of Molecular Medicine at the Rudjer Boskovic Institute, Zagreb, Croatia. Dr. Gall Troselj is particularly interested in modulation of the epigenome by natural compounds, especially curcumin, in the context of chemoprevention. She has developed a fruitful collaboration with Croatian clinicians, especially oncologists, head and neck surgeons and pathologists. Her current national research project, funded by the Croatian Science Foundation (NRF2 at the crossroads of epigenetic remodeling, metabolism and proliferation of cancer cells), is focused on discovering mechanisms of NRF2 and EZH2 interplay in a setting of various kinds of cellular stresses to which cancer cells are or may be exposed.
Advertisement
Follow
Annual Journal Metrics
-
Speed
56 days to first decision for reviewed manuscripts only
50 days to first decision for all manuscripts
114 days from submission to acceptance
12 days from acceptance to publicationCitation Impact
3.439 - 2-year Impact Factor
3.618 - 5-year Impact Factor
1.005 - Source Normalized Impact per Paper (SNIP)
1.180 - SCImago Journal Rank (SJR)Usage
385,203 Downloads
153 Altmetric mentions
On the blog
-
Breast Cancer Quiz 2019
30 September 2019
-
Sharing data for the benefit of children with cancer
09 September 2019
-
Blood Cancer Awareness Quiz
06 September 2019
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).
Funding your APC
Advertisement
